BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 29, 2018
View Archived Issues
Prothena reorganizing resources to advance neuroscience pipeline
Read More
Researchers present novel bifunctional mu-receptor agonist and NPFF receptor antagonist, KGFF-09
Read More
Novel experimental model of ZIKV infection with pregnant common marmoset presented
Read More
Mouse model of VIPR2 gene copy number variation gives insight into neuropsychiatric disorders
Read More
Researchers present new antiviral compounds
Read More
EMA accepts European filing for edaravone for ALS
Read More
New IDO-1 inhibitor PX-D26116 has improved metabolic stability compared to epacadostat
Read More
Actavalon patents AhR agonists for cancer
Read More
Wuhan Bowo Biological Technology divulges new influenza and RSV vaccines
Read More
Centogene collaborates with Aldeyra Therapeutics in Sjogren-Larsson syndrome
Read More
AB Science offers update on European MAA for masitinib in ALS
Read More
JCR obtains approval in Brazil to begin phase II trial of JR-141 for Hunter's syndrome
Read More
ImmuPharma releases further data analysis from pivotal trial of Lupuzor in SLE
Read More
FDA grants orphan drug designation to SNX-5422 for neuroendocrine tumors
Read More
Tazemetostat granted U.S. orphan drug designation for chordoma
Read More
Arroyo BioSciences' AB-22 granted U.S. orphan drug designation for IPF
Read More
FDA approves Cimzia for the treatment of adults with moderate to severe plaque psoriasis
Read More
IDMC recommends continuation of phase III study of Zepsyre in small cell lung cancer
Read More
FDA grants priority review for gilteritinib NDA in relapsed or refractory AML
Read More
REXGEX trial shows importance of immune status for enhanced efficacy with CetuGEX
Read More
Chugai seeks Japanese approval for Actemra for cytokine release syndrome
Read More
Japanese approval sought for Trelegy Ellipta
Read More
Kowa to launch Parmodia in Japan for hyperlipidemia
Read More
Researchers discover new targets for lymphoblastic leukemia immunotherapy
Read More
Pfizer seeks Japanese approval of dacomitinib for EGFR mutation-positive NSCLC
Read More
Phase III IMpower130 study of Tecentriq in NSCLC meets coprimary endpoints
Read More